{"id":"NCT01322490","sponsor":"Bavarian Nordic","briefTitle":"A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer","officialTitle":"A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11-28","primaryCompletion":"2017-09-25","completion":"2017-12-15","firstPosted":"2011-03-24","resultsPosted":"2019-08-08","lastUpdate":"2019-09-04"},"enrollment":1297,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer Metastatic"],"interventions":[{"type":"BIOLOGICAL","name":"PROSTVAC-V","otherNames":[]},{"type":"BIOLOGICAL","name":"PROSTVAC-F","otherNames":[]},{"type":"DRUG","name":"GM-CSF","otherNames":[]},{"type":"OTHER","name":"GM-CSF Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"PROSTVAC-V/F-TRICOM + GM-CSF","type":"EXPERIMENTAL"},{"label":"PROSTVAC-V/F-TRICOM + GM-CSF placebo","type":"EXPERIMENTAL"},{"label":"Placebo Control","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from metastatic, castrate-resistant prostate cancer.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"Randomization through the date of death due to any cause. Subjects were followed up for approximately 6 years from the first subject randomized to the completion of the study.","effectByArm":[{"arm":"PROSTVAC-V/F-TRICOM + GM-CSF Placebo","deltaMin":34.4,"sd":null},{"arm":"PROSTVAC-V/F-TRICOM + GM-CSF","deltaMin":33.2,"sd":null},{"arm":"Placebo Control","deltaMin":34.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.4742"},{"comp":"OG001 vs OG002","p":"0.5885"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":220,"countries":["United States","Australia","Belgium","Canada","Denmark","Estonia","France","Germany","Iceland","Israel","Netherlands","Poland","Puerto Rico","Russia","Spain","United Kingdom"]},"refs":{"pmids":["30817251"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":56,"n":429},"commonTop":["Injection site erythema","Injection site pain","Fatigue","Injection site pruritus","Injection site swelling"]}}